BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pavlidou A, Kroupis C, Dimas K. Association of survivin splice variants with prognosis and treatment of breast cancer. World J Clin Oncol 2014; 5(5): 883-894 [PMID: 25493226 DOI: 10.5306/wjco.v5.i5.883]
URL: https://www.wjgnet.com/1007-9327/full/v5/i5/883.htm
Number Citing Articles
1
Brian J. Czerniecki, Nadia Nocera, Lea Lowenfeld, Lori Showalter, Gary Koski. Trends in Breast Cancer Prevention2016; : 253 doi: 10.1007/978-3-319-27135-4_10
2
Mohammad-Reza Mahmoudian-Sani, Arash Alghasi, Ali Saeedi-Boroujeni, Akram Jalali, Mohammad Jamshidi, Ali Khodadadi. Survivin as a diagnostic and therapeutic marker for thyroid cancerPathology - Research and Practice 2019; 215(4): 619 doi: 10.1016/j.prp.2019.01.025
3
Xiao-Zhou Liu, Cheng-Jun Li, Su-Jia Wu, Xin Shi, Jian-Ning Zhao. Involvement of α5 integrin in survivin-mediated osteosarcoma metastasisAsian Pacific Journal of Tropical Medicine 2016; 9(5): 478 doi: 10.1016/j.apjtm.2016.03.022
4
Ludovica Taglieri, Francesca De Iuliis, Anna Giuffrida, Sabrina Giantulli, Ida Silvestri, Susanna Scarpa. Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cellsOncology Letters 2017; 14(3): 3832 doi: 10.3892/ol.2017.6597
5
Neerada Meenakshi Warrier, Prasoon Agarwal, Praveen Kumar. Emerging Importance of Survivin in Stem Cells and Cancer: the Development of New Cancer TherapeuticsStem Cell Reviews and Reports 2020; 16(5): 828 doi: 10.1007/s12015-020-09995-4
6
Joji Iida, Elisabeth T. Bell-Loncella, Marc L. Purazo, Yifeng Lu, Jesse Dorchak, Rebecca Clancy, Julianna Slavik, Mary Lou Cutler, Craig D. Shriver. Inhibition of cancer cell growth by ruthenium complexesJournal of Translational Medicine 2016; 14(1) doi: 10.1186/s12967-016-0797-9
7
Christiana M. Neophytou, Avgoustinos Mesaritis, Gregoria Gregoriou, Andreas I. Constantinou. d-a-Tocopheryl Polyethylene Glycol 1000 Succinate and a small-molecule Survivin suppressant synergistically induce apoptosis in SKBR3 breast cancer cellsScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-50884-9
8
Zhu-Qing Liu, Ying-Chao Han, Jue-Min Fang, Fei Hu, Xi Zhang, Qing Xu. WITHDRAWN: Hypoxia-induced STAT3 contributes to chemoresistance and epithelial–mesenchymal transition in prostate cancer cellsBiochemical and Biophysical Research Communications 2015;  doi: 10.1016/j.bbrc.2015.02.027
9
Efsun Eren-Keleş, Halil Gürhan Karabulut, Hasan Fatih Çakmaklı, Başak Adaklı, Serdar Kenan Köse, Handan Uğur-Dinçaslan, Gülsan Yavuz, Mehmet Ertem, Ajlan Tükün. Expression of Survivin and Its Splice Variants in Pediatric Acute Lymphoblastic LeukemiaGenetic Testing and Molecular Biomarkers 2018; 22(12): 680 doi: 10.1089/gtmb.2018.0152
10
Nancy Martínez-Montiel, Maricruz Anaya-Ruiz, Martín Pérez-Santos, Rebeca Martínez-Contreras. Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic ToolsGenes 2017; 8(10): 217 doi: 10.3390/genes8100217
11
Glaucia Luciano da Veiga, Raissa Daniel Machado da Silva, Edimar Cristiano Pereira, Ligia Ajaime Azzalis, Beatriz da Costa Aguiar Alves, Flavia de Sousa Gehrke, Thaís Moura Gascón, Fernando Luiz Affonso Fonseca. The role of Survivin as a biomarker and potential prognostic factor for breast cancerRevista da Associação Médica Brasileira 2019; 65(6): 893 doi: 10.1590/1806-9282.65.6.893
12
Vladimir N. Uversky. (Intrinsically disordered) splice variants in the proteome: implications for novel drug discoveryGenes & Genomics 2016; 38(7): 577 doi: 10.1007/s13258-015-0384-0
13
Eman El Zeneini, Sarah Kamel, Mahmoud El-Meteini, Asma Amleh. Knockdown of COBRA1 decreases the proliferation and migration of hepatocellular carcinoma cellsOncology Reports 2017; 37(3): 1896 doi: 10.3892/or.2017.5390
14
Matthew M. Yeh, Sarag Boukhar, Benjamin Roberts, Nairanjana Dasgupta, Sayed S. Daoud. Genomic variants link to hepatitis C racial disparitiesOncotarget 2017; 8(35): 59455 doi: 10.18632/oncotarget.19755
15
Minna Turkkila, Karin M.E. Andersson, Sylvie Amu, Mikael Brisslert, Malin C. Erlandsson, Sofia Silfverswärd, Maria I. Bokarewa. Suppressed diversity of survivin splicing in active rheumatoid arthritisArthritis Research & Therapy 2015; 17(1) doi: 10.1186/s13075-015-0689-z
16
Matthew Brown, Wanbin Zhang, Deyue Yan, Rajath Kenath, Le Le, He Wang, Daniel Delitto, David Ostrov, Keith Robertson, Chen Liu, Kien Pham, Andrei L. Gartel. The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therapeutic for PDACPLOS ONE 2020; 15(1): e0226917 doi: 10.1371/journal.pone.0226917
17
Qi Xie, Qiulian Wu, Stephen C. Mack, Kailin Yang, Leo Kim, Christopher G. Hubert, William A. Flavahan, Chengwei Chu, Shideng Bao, Jeremy N. Rich. CDC20 maintains tumor initiating cellsOncotarget 2015; 6(15): 13241 doi: 10.18632/oncotarget.3676
18
Jerry Xiao, Joseph R. McGill, Apsra Nasir, Alexander Lekan, Bailey Johnson, Devan J. Wilkins, Gray W. Pearson, Kandice Tanner, Hani Goodarzi, Eric Glasgow, Richard Schlegel, Seema Agarwal. Identifying drivers of breast cancer metastasis in progressively invasive subpopulations of zebrafish-xenografted MDA-MB-231Molecular Biomedicine 2022; 3(1) doi: 10.1186/s43556-022-00080-5
19
Javier Gaytan-Cervantes, Carolina Gonzalez-Torres, Vilma Maldonado, Cecilia Zampedri, Gisela Ceballos-Cancino, Jorge Melendez-Zajgla. Protein Sam68 regulates the alternative splicing of survivin DEx3Journal of Biological Chemistry 2017; 292(33): 13745 doi: 10.1074/jbc.M117.800318